Theorem Clinical Research

R&D Trends

Epirus, Livzon Mabpharm collaborate in China

Wednesday, October 8, 2014 12:00 PM

Epirus Biopharmaceuticals, a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, has signed a royalty-bearing, multi-product collaboration agreement with Livzon Mabpharm, a Chinese biotechnology company focused on the development, manufacture and sale of antibody-based drugs.

More... »


Tenax Therapeutics halts phase IIb trial

Tuesday, October 7, 2014 01:00 PM

Tenax Therapeutics, formerly named Oxygen Biotherapeutics, a Morrisville, N.C.-based specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, has announced that the company, with unanimous approval from the board of directors, has elected to stop the current phase IIb trial for its Oxycyte drug candidate and consider strategic alternatives for the program moving forward. The company will review the data generated on the patients enrolled in the trial to date.

More... »


HUYA Bioscience International, Tianjin Institute of Pharmaceutical Research partner

Tuesday, October 7, 2014 09:30 AM

HUYA Bioscience International, an accelerator of the global development of China’s pharmaceutical innovations, has announced a joint venture with Tianjin Institute of Pharmaceutical Research (TIPR) to develop medical technologies and therapies, originating in both China and the western world, for global markets.

More... »

John O´Keefe, May-Britt Moser, Edvard I. Moser win Nobel prize

Monday, October 6, 2014 03:36 PM

The Nobel Assembly at Karolinska Institute has awarded the 2014 Nobel Prize in Physiology or Medicine to John O´Keefe and jointly to May-Britt Moser and Edvard I. Moser for their discoveries of cells that constitute a positioning system in the brain.

More... »

DIA, Korea National Enterprise for Clinical Trials ink MoU

Friday, October 3, 2014 11:02 AM

Korea National Enterprise for Clinical Trials (KoNECT) and DIA (Drug Information Association), based in Washington, D.C., have signed a Memorandum of Understanding (MoU) to establish a cooperative relationship and explore collaboration in development of training, education and knowledge exchange opportunities.

More... »

Report: Small and medium-sized enterprises are driving innovation in medicines

Thursday, October 2, 2014 02:28 PM

Micro, small and medium-sized enterprises (SMEs) are a motor of innovation in the European Union (E.U.). Between 2010 and 2012, more than one in four new innovative medicines recommended for marketing authorization in the E.U. originated from SMEs, as shown in an analysis published by the EMA in January. 

More... »

With NIH Grant, Cedars-Sinai brings big data to neuro disease research

Thursday, October 2, 2014 02:23 PM

Investigators at the Los Angeles Cedars-Sinai Regenerative Medicine Institute have received a grant from the NIH to participate in a consortium taking the study of motor neuron disorders—such as Lou Gehrig's disease and spinal muscular atrophy—to a new, comprehensive perspective.

More... »

CORD:USE, Tianhe Stem Cell Biotechnologies partner

Thursday, October 2, 2014 02:20 PM

CORD:USE Cord Blood Bank, headquartered in Orlando, Fla., an operator of both public and family cord blood banks, has entered into an agreement with Illinois–based Tianhe Stem Cell Biotechnologies, which has licensed a series of patented technologies for the isolation of human cord blood-derived multipotent stem cells for possible clinical applications.

More... »

National MS Society invests nearly $19 million in MS research

Thursday, October 2, 2014 02:16 PM

The National Multiple Sclerosis (MS) Society has committed nearly $19 million to support an expected 54 new MS research projects. These are part of a comprehensive research strategy aimed at stopping MS, restoring function that has been lost and ending the disease forever.

More... »

BioNTech, Ganymed Pharmaceuticals open research headquarters in Germany

Thursday, October 2, 2014 02:14 PM

BioNTech and Ganymed Pharmaceuticals, two German biotechology companies, have opened a 108,000-square-foot headquarters and research facility. The new facility brings together 300 employees and is located near academic institutions, hospitals and cancer research institutions.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 20

Toronto Star, with FDA data, exposes weaknesses in Health Canada's clinical trial, inspection oversight

Crowdsourcing effort aims to fund updated online social media guide for sponsor interaction with patients

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs